THE GENERAL ASSEMBLY OF THE HUNGARIAN BIOTECHNOLOGY ASSOCIATION ELECTS ITS NEW BOARD

Proud to share that VRG Therapeutics is entering a co-development partnership and option agreement with AOP Health to advance a new immunology program.
This collaboration brings together our AI-driven miniprotein discovery platform with AOP Health’s clinical development expertise, with the shared goal of accelerating a novel immune cell activity regulator toward first-in-human studies for autoimmune and inflammatory diseases.
Excited for what’s ahead!

Our team attended the Swiss Biotech Day - great connections and inspiring discussions throughout the event.

It also provided valuable inspiration for the renewing Hungarian Biotechnology Association. 🌱

Hopefully, we’ll see HBA represented in the Global Village next year and maybe, in a few years, we’ll be hosting a similar event in Hungary.

Thanks to the Swiss Biotech Association for the excellent organization.

Another proud moment for the Hungarian biotech 🚀

Big news from one of our members: Turbine has closed a $25M Series B round, led by Interactive Venture Partners with participation from Beiersdorf Venture Capital.

📍 Yesterday we held our first strategy meetup since the renewal.